Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy

被引:3
|
作者
O'Donnell, K. [1 ]
Adin, D. [1 ]
Atkins, C. E. [1 ]
DeFrancesco, T. [1 ]
Keene, B. W. [1 ]
Tou, S. [1 ]
Meurs, K. M. [1 ]
机构
[1] North Carolina State Univ, Coll Vet Med, Dept Vet Clin Sci, A227,1060 William Moore Dr, Raleigh, NC 27607 USA
关键词
cardiomyopathy; feline; genetic; HCM; mutation;
D O I
10.1111/age.13074
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Hypertrophic cardiomyopathy (HCM) is the most common cause of heart disease in the domestic cat with a genetic predisposition in a few breeds. In the Maine Coon and Ragdoll breeds, two variants associated with the HCM phenotype have been identified in the cardiac myosin binding protein C gene (MYBPC3; p.Ala31Pro and p.Arg820Trp respectively), and a single variant has been identified in the myosin heavy chain gene (MYH7; p.Glu1883Lys) in one domestic cat with HCM. It is not known if these variants influence the development of HCM in other cohorts of the feline population. The objective of this study was to evaluate the presence of the known MYBPC3 and MYH7 variants in a population of cats with HCM. DNA was isolated from samples collected from non-Ragdoll and non-Maine Coon domestic cats diagnosed with HCM through the North Carolina State University College of Veterinary Medicine and genotyped for the three variants. One-hundred and three DNA samples from cats with HCM were evaluated from domestic shorthair, domestic longhair and purebred cats. All samples were wt for the MYBPC3 and MYH7 variants. Although this study was limited by its inclusion of cats from one tertiary hospital, the lack of these MYBPC3 and MYH7 variants in this feline HCM population indicates that the clinical utility of genetic testing for these variants may be isolated to the two cat breeds in which these variants have been identified. Further studies to identify the causative variants for the feline HCM population are warranted.
引用
收藏
页码:542 / 544
页数:3
相关论文
共 50 条
  • [41] Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction
    Timmer, Stefan A. J.
    Germans, Tjeerd
    Brouwer, Wessel P.
    Lubberink, Mark
    van der Velden, Jolanda
    Wilde, Arthur A. M.
    Christiaans, Imke
    Lammertsma, Adriaan A.
    Knaapen, Paul
    van Rossum, Albert C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (12) : 1283 - 1289
  • [42] Novel mutations in MYH7 and MYPBC3 of an Indian family causing hypertrophic cardiomyopathy
    Sakthivel, S
    Waldmüller, S
    Saadi, A
    Joseph, PK
    Rakesh, PG
    Padmakumar, R
    Tharakan, JM
    Richard, P
    Schwartz, K
    Rajamanickam, C
    Vosberg, HP
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A105 - A105
  • [43] Hypertrophic cardiomyopathy in a large cohort of MYBPC3 c.927-2A>G founder mutation carriers
    Adalsteinsdottir, B.
    Burke, M. A.
    Teekakirikul, P.
    Maron, B. J.
    Danielsen, R.
    Seidman, C. E.
    Seidman, J. G.
    Gunnarsson, G. T.
    EUROPEAN HEART JOURNAL, 2014, 35 : 924 - 924
  • [44] Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants
    Manhas, Amit
    Jahng, James W. S.
    Vera, Carlos D.
    Shenoy, Sushma P.
    Knowles, Joshua W.
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 61
  • [45] Resequencing the Whole MYH7 Gene (Including the Intronic, Promoter, and 3′ UTR Sequences) in Hypertrophic Cardiomyopathy
    Coto, Eliecer
    Reguero, Julian R.
    Palacin, Maria
    Gomez, Juan
    Alonso, Belen
    Iglesias, Sara
    Martin, Maria
    Tavira, Beatriz
    Diaz-Molina, Beatriz
    Morales, Carlos
    Moris, Cesar
    Rodriguez-Lambert, Jose L.
    Corao, Ana I.
    Diaz, Marta
    Alvarez, Victoria
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (05): : 518 - 524
  • [46] Lower than expected mutation frequency in MYH7 gene in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy
    Laredo-Vazquez, R.
    Monserrat, L.
    Hermida, M.
    Medin, M.
    Rodriguez, I.
    Fernandez, X.
    Muniz, J.
    Castro-Beiras, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 391 - 392
  • [47] The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humans
    Ripoll Vera, Tomas
    Monserrat Iglesias, Lorenzo
    Hermida Prieto, Manuel
    Ortiz, Martin
    Rodriguez Garcia, Isabel
    Govea Callizo, Nancy
    Gomez Navarro, Carlos
    Rosell Andreo, Jordi
    Gamez Martinez, Jose Maria
    Pons Llado, Guillermo
    Cremer Luengos, David
    Torres Marques, Joan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (02) : 405 - 407
  • [48] Myocardial energetic impairment differs in pre-hypertrophic carriers with mutations in MYH7 and MYBPC3-a PET and MRI study
    Guclu, A.
    Knaapen, P.
    Harms, H. J.
    Vermeer, A. M. C.
    Wilde, A. A. M.
    Lammertsma, A. A.
    Van Rossum, A. C.
    Germans, T.
    Van der Velden, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 693 - 693
  • [49] Phenotypical variants in β-MYH7 mutation-related hypertrophic cardiomyopathy: role of LGE-CMR for risk stratification of SCD
    Badii, M. C.
    Gauthey, A.
    Scavee, C.
    De Waroux, B. Le Polain
    Marchandise, S.
    Garnir, Q.
    Wauters, A.
    Phlips, T.
    ACTA CARDIOLOGICA, 2019, 74 (05) : 454 - 455
  • [50] Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy
    Haq, Ikram U.
    Akhiyat, Nadia
    Al-Shakarchi, Nader
    Siontis, Konstantinos C.
    Mulpuru, Siva K.
    Sugrue, Alan
    Giudicessi, John
    Friedman, Paul A.
    Asirvatham, Samuel J.
    Killu, Ammar M.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (07) : 1380 - 1391